Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Brain : a Journal of Neurology|June 17, 2008
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degenerationXuebao Zhang, Clement Y Chow, Zarife Sahenk, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Follistatin Gene Therapy Improves Ambulation in Becker Muscular DystrophySamiah A Al-Zaidy, Zarife Sahenk, Louise R Rodino-Klapac, et al.
Neurodegenerative Disease Management|September 2, 2021
Unmet needs and evolving treatment for limb girdle muscular dystrophiesEric Pozsgai, Danielle Griffin, Rachael Potter, et al.
Molecular Therapy. Advances|May 15, 2026
Autophagy activation via BAG3 gene therapy improves phenotype in a mouse model of LGMD1ABurcak Ozes, Lingying Tong, Kyle Moss, et al.
Brain and Behavior|September 22, 2018
Efficacy of exogenous pyruvate in Trembler<sup>J</sup> mouse model of Charcot-Marie-Tooth neuropathyZarife Sahenk, Mehmet E Yalvac, Jakkrit Amornvit, et al.
Human Molecular Genetics|August 14, 2010
A humanized Smn gene containing the SMN2 nucleotide alteration in exon 7 mimics SMN2 splicing and the SMA disease phenotypeJordan T Gladman, Thomas W Bebee, Chris Edwards, et al.
Journal of Neuropathology and Experimental Neurology|April 16, 2026
The NORAD-Pumilio regulatory axis in the evolution of inclusion body myositisLingying Tong, Burcak Ozes, Kyle Moss, et al.
Neuroscience Letters|May 22, 2012
Gene therapy for muscular dystrophy: lessons learned and path forwardJerry R Mendell, Louise Rodino-Klapac, Zarife Sahenk, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1Zarife Sahenk, Burcak Ozes, Darren Murrey, et al.
Pageof 8